In both ovarian carcinoma and breast cancer, RDM1 also plays an oncogenic role,7 whereas in hepatocellular carcinoma, RDM1 expression is decreased, and RDM1 silencing enhances cancer procession via p53 and Ras/Raf/ERK signalling pathway.3 Here, RDM1 is linked to cancer.